Preview: Cara Therapeutics's Earnings
Portfolio Pulse from Benzinga Insights
Cara Therapeutics (NASDAQ:CARA) is set to release its quarterly earnings report on August 7, 2023. Analysts estimate an earnings per share (EPS) of $-0.56. The company's past performance shows a pattern of share price changes following earnings reports. The stock is currently trading at $3.19, down 72.13% over the last 52-week period.
August 04, 2023 | 4:01 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Cara Therapeutics is expected to report an EPS of $-0.56. The company's stock price has historically been affected by earnings reports. The stock is currently down 72.13% over the last year.
Cara Therapeutics' stock price has historically been affected by its earnings reports. Given the negative EPS estimate and the stock's poor performance over the last year, it's likely that the stock price will continue to be negatively affected in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100